Resp Care
-
No studies have examined the clinical utility of arterial blood gas (ABG) values during spontaneous breathing trials (SBTs) for making extubation decisions. Nonetheless many intensive care units measure ABGs during an SBT to determine, in conjunction with other data, whether the SBT was successful. ⋯ These data suggest that ABG values did not change extubation decisions in 93% of cases. However, in 7 cases the ABG values changed the extubation decision. If even a few of those cases would have failed extubation without knowledge of the ABG values, the increased patient risk and cost associated with failed extubation would more than offset the relatively small cost of collecting ABG values from all patients who undergo SBT.
-
We describe a laboratory investigation comparing the delivery of chlorofluorocarbon (CFC)- and hydrofluoroalkane (HFA)-formulated beclomethasone dipropionate (BDP) by metered-dose inhaler and holding chamber (AeroChamber HC MV) in a simulation of a mechanically ventilated adult patient. ⋯ Total emitted mass for HFA-BDP was increased by a factor of 5.8 compared with CFC-BDP, due largely to the finer particle size distribution of the HFA-based solution formulation. Additional water vapor required to operate the breathing circuit at close to body conditions resulted in fine particle growth with both formulations.